The EHS Task Force has been set up due to the considerable success with the launching of the European Health Summit last December in 2020. This platform has been designed to drive policy in the domain of health, aside from organizing high-level annual events.
The aim is not only to create a larger healthcare network and provide visibility, but also to be able to steer the process of policy making at the European level and strengthen the link between public and private partnership through the involvement of cross-sectorial stakeholders.
PROGRAMME OF 2021
30 March 2021
WORKING GROUP 1 (CLOSED MEETING): Pandemics and vaccines, HERA Incubator
23 April 2021 – 10:00 AM CET
EHS TASK FORCE PUBLIC DEBATE: PANDEMICS AND VACCINES, HERA INCUBATOR
DG SANTÉ, European Commission
Deputy Director General
Financial Times Brussels Correspondent
I3h Institute, ULB
Member of the European Parliament
Strategy Advisor to CEO, CEPI
Former CEO, GSK Vaccines
Global Director rare diseases and vaccines
Advisor to the Belgian Prime Minister
Regional business leader health and life sciences EMEA
What is Europe’s strategy in combating COVID-19 strains?
The first public event of the EHS Task Force will debate the Commission’s work on emergency preparedness and the EU’s capacity to swiftly secure access to the necessary vaccines, whenever needed. Join our discussion on HERA (European Health Emergency Preparedness and Response Authority) Incubator.
WORKING GROUP 2 (CLOSED MEETING): EUROPEAN HEALTH DATA SPACE (USE OF RWD data, validating use of secondary data)
EHS Task Force PUBLIC DEBATE – EUROPEAN HEALTH DATA SPACE
24 May 2021
Orientation Session for Working Group 3 (CLOSED MEETING)- INNOVATIVE MEDICINE, RARE DISEASES, ADVANCED THERAPIES
8 June 2021
Working group 3 (CLOSED MEETING): Innovative medicine, rare diseases, advanced therapies
29 June 2021
EHS Task Force PUBLIC debate: Innovative medicine, rare diseases, advanced therapies
Working Group 4 (CLOSED MEETING): HERA STATUS